Results 191 to 200 of about 76,984 (297)

POSSIBLE TACROLIMUS ACTION MECHANISMS IN ITS PROTECTOR EFFECTS ON ISCHEMIA-REPERFUSION INJURY

, 1998
Francisco Javier García‐Criado, Francisco S. Lozano-Sanchez, Javier Fernandez-Regalado, J.J. Valdunciel-Garcia, Felipe Carlos Parreño Manchado, Isabel Silva-Benito, Yolanda Zambrano-Cuadrado, Alberto Gómez-Alonso   +7 more
openalex   +1 more source

Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection [PDF]

, 1997
Ramin Naraghi, D.A Smith, Ron Shapiro, Carlos Vivas, H. Albin Gritsch, Velma P. Scantlebury, J McCauley, Parmjeet Randhawa, Anthony J. Demetris, John McMichael, John J. Fung, Thomas E. Starzl, Mark L. Jordan   +12 more
openalex   +1 more source

Neurological manifestations of chronic graft versus host disease

Internal Medicine Journal, EarlyView.
Abstract Introduction Allogeneic haemopoietic stem cell transplant (allo‐HSCT) is an established therapy for many malignant and non‐malignant conditions, with an increasing number of uses and indications in recent decades. Complications including graft versus host disease (GvHD) carry significant morbidity and mortality.
Tal Koren, Alice Kwok, William Stevenson, Kate Ahmad, Joseph Nogajski, John Parratt, Ian Kerridge, Karl Ng   +7 more
wiley   +1 more source

Palmitoylethanolamide (PEA) Induces an Increase in Spleen Regulatory T Cells, Reduces CD8+ Cells and TNF‐α Levels in Target Organs, and Protects Mice From Graft‐Versus‐Host Disease‐Related Mortality Through PPAR Activation Without Compromising the Graft‐Versus‐Tumour Response

Immunology, EarlyView.
Effect of Palmitoylethanolamide (PEA) in a murine model of graft‐versus‐host disease (GVHD). Following an allogeneic transplant from C57BL/6J donors to BALB/c recipients, PEA treatment improved survival, alleviated clinical symptoms, and protected target organs in GVHD‐affected mice.
Bárbara Betônico Berg, Zara Desiree Tonidandel Campos, Gioconda Muniz Fiorenza Ruggio, Ana Flávia Santos Linhares, Bárbara Maximino Rezende, Stêfany Bruno de Assis Cau, Thiago Roberto Lima Romero, Mauro Martins Teixeira, Vanessa Pinho, Marina Gomes Miranda Castor   +9 more
wiley   +1 more source

Tacrolimus Trough Concentrations are Not Impacted by Epstein-Barr Virus Serology and Viral Load in Pediatric Liver Transplant Recipients. [PDF]

Eur J Drug Metab Pharmacokinet
Te Lintelo AM, van Wier LF, van der Doef HPJ, Kosterink JGW, Scheenstra R, van Leer CC, Bourgonje AR, Touw DJ, Mian P.   +8 more
europepmc   +1 more source

Impact of Immunosuppressive Drugs on Patients With Percutaneous Left Atrial Appendage Occlusion

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Percutaneous left atrial appendage closure (LAAC) reduces the risk of thromboembolic stroke in patients with non‐valvular atrial fibrillation who cannot tolerate long‐term oral anticoagulation. However, outcomes after LAAC in patients requiring chronic immunosuppressive therapy (IMS) remain unknown. This study aimed to investigate
Daisuke Togashi, Christopher R. Ellis, Zachary T. Yoneda, Jackon G. Gregory, Shunsuke Uetake, Salah H. Alahwany, Michael T. Baker, Arvindh N. Kanagasundram   +7 more
wiley   +1 more source

Risk of malignant neoplasms of tacrolimus in kidney transplant patients: a retrospective cohort study conducted using the Japanese National Database of Health Insurance Claims. [PDF]

BMC Nephrol
Kubota R, Sada KE, Tokunaga M, Yoshinaga K, Yamanoi T, Kawada T, Tominaga Y, Sadahira T, Katayama S, Iwata T, Nishimura S, Bekku K, Edamura K, Kobayashi T, Nakagawa Y, Ichimaru N, Wada K, Araki M.   +17 more
europepmc   +1 more source

CHEMIN—Results From the National Practice Survey in Chronic Hand Eczema Therapeutic Management

Contact Dermatitis, EarlyView.
Claire Bernier, Marie‐Noëlle Crépy, Bruno Halioua, Camille Leleu, Marina Schverer, Solenn Le Clanche, Marie Tauber, Angèle Soria   +7 more
wiley   +1 more source

SINUS ARREST DURING TACROLIMUS TREATMENT: WAS THE QT INTERVAL PROLONGED?

, 1998
Salvatore Calandra
openalex   +1 more source

Clinical heterogeneity in vitiligo: Identification of clinical markers based patient clusters

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Vitiligo is a chronic autoimmune disease with heterogeneous clinical presentations. This study analysed 399 patients using hierarchical clustering and identified five phenotypes based on clinical characteristics and lesion distribution. Two groups exhibited high disease activity and extensive involvement.
Laura Galissi, Tristan Benoît, Ribal Merhi, Claire Drullion, Nicolas Andreu, Khaled Ezzedine, Thomas Darde, Katia Boniface, Julien Seneschal   +8 more
wiley   +1 more source